ATOS

Atossa Therapeutics, Inc.

Sector: healthcareBiotechnologyNASDAQMarket Cap: $36.3M

Atossa Therapeutics is a clinical-stage biopharmaceutical company developing therapeutics for breast cancer and other conditions, with its primary political signal being exposure to 8 high-impact healthcare bills each estimated to affect over $4.8M in revenue.

Next filing → your inbox

Govt Dependence

10/100

Regulatory Density

85/100

Lobbying Intensity

0/100

Political Signal

NEUTRAL

BusinessWhat ATOS does

Atossa Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics in oncology and infectious disease, with a lead program in breast cancer. Its revenue is minimal and primarily from research collaborations, as it is pre-commercial and funded through equity offerings. The company's value is tied to clinical trial outcomes and regulatory milestones for its drug candidates.

12 months past · 3 months futureATOS activity timeline

Congress

buy sell

Insider · Form 4

open-market buy

Hedge fund · 13F

opened + added − trimmed closed holds

Bills

past action (this ticker) upcoming markup (sector) ★ carveout (this ticker)

245 trading days · 0 congressional trades shown · 0 insider buys · 6 13F filings · 3 past bill actions · 9 upcoming markups

Lifetime Government AwardsATOS federal contracts

ATOS doesn't hold direct federal contracts.

Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.

Smart Money · 13F HoldingsHedge funds holding ATOS

$573.8M

Total ATOS held by tracked 13F funds

Funds with ATOS positions

Renaissance Technologies $573M -95% 2026-03-31

Citadel Advisors $382K +146% 2025-12-31

Congressional TradesWho in Congress is trading ATOS

2017-10-25 Roger Marshall R-Kansas · senate Purchase $1,001 - $15,000 285d late

2017-10-25 Roger Marshall R-Kansas · senate purchase $1,001 - $15,000 285d late

2+ trades on file · most recent 2018-08-06

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Stock awards & option exercises

stock awards · $604K market value

2026-03-27 QUAY STEVEN C President & CEO AWARD 65,000 sh $307K

2026-03-26 Daniel Mark James Chief Financial Officer AWARD 63,000 sh $297K

For ATOS, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.

Bills Affecting ATOSLive legislation impacting this stock

HR.184 · 119th

Action Versus No Action Act

Committee latest action 2026-05-21 8% impact MEDIUM

HR.210 · 119th

Dental Care for Veterans Act

Committee latest action 2026-05-20 6% impact MEDIUM

HR.109 · 119th

TEAM Veteran Caregivers Act

Committee latest action 2025-12-19 8% impact MEDIUM

HR.290 · 119th

Rural Telehealth and Education Enhancement Act of 2025

Committee latest action 2025-02-14 9% impact MEDIUM

HR.255 · 119th

To name the Department of Veterans Affairs community-based outpatient clinic in Lubbock, Texas, as the "General Bernie Mittemeyer

Committee latest action 2025-02-11 6% impact MEDIUM

HR.219 · 119th

Improving Menopause Care for Veterans Act of 2025

Committee latest action 2025-02-11 6% impact MEDIUM

HR.27 · 119th

HALT Fentanyl Act

Committee latest action 2025-02-10 8% impact MEDIUM

HR.150 · 119th

People CARE Act

Committee latest action 2025-02-07 8% impact MEDIUM

HR.211 · 119th

Equal Access to Contraception for Veterans Act

Committee latest action 2025-02-06 6% impact MEDIUM

HR.149 · 119th

Lead by Example Act of 2025

Committee latest action 2025-02-06 6% impact MEDIUM

Political ProfileWhere ATOS sits in Washington

[object Object]

STRUCTURAL: High exposure to healthcare legislation (8 bills with impact_ratios >0.13). EVIDENTIARY: No political footprint: zero lobbying spend (`get_political_influence.lobbying.total_income: 0`), zero donations, zero insider buys (`get_corporate_insider_signal.total_buys: 0`), and zero congressional trades. Net: Pure regulatory exposure without mitigating political engagement.

Regulatory ExposureThreats & opportunities

Regulatory threats

High regulatory density for drug development and approval

FDA

"Inferred from sector; `Recent bill_impacts` shows 8 healthcare bills with impact_ratios from 0.1344 to 0.1415."

Regulatory opportunities

Potential for favorable legislation impacting healthcare revenue

Congress

"`Recent bill_impacts` shows multiple bills with positive estimated_revenue_impact, ranging from $4.87M to $5.13M."

Member intelligence layer

Live signals + predictions for ATOS — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Live 7-layer signal scores when Congress trades ATOS
Bill Pass Index v2 odds for every bill on the watch list
Iron Triangle alerts (committee × donor × trade)
SEC Form 4 cluster detection (CEO + CFO + director buys)
Whale-Opportunity expected-value ranking
Custom watchlist alerts via email + Discord

Become a Founder · $24.50/mo Locked rate forever · cancel anytime

Frequently AskedAbout ATOS & political exposure

Does Atossa Therapeutics, Inc. (ATOS) hold federal contracts?

No direct prime contracts reported in USASpending.gov for Atossa Therapeutics, Inc.. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.

Has Congress traded ATOS stock?

2 congressional trades by 1 unique members of Congress, most recently on 2017-10-25. See the Congressional Trading panel for politician-by-politician breakdown.

What is ATOS political risk profile?

Government dependence: 10/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.

How does GovGreed track ATOS political activity?

GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. ATOS data is updated daily from these official federal sources.